# PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)

> **NCT04806854** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Lumos Pharma** · enrollment: 24 (estimated)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** LUM-201

## Key facts

- **NCT ID:** NCT04806854
- **Lead sponsor:** Lumos Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-14
- **Primary completion:** 2030-04
- **Final completion:** 2030-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04806854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04806854, "PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04806854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*